Clinical trial
Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases
NCT01787162 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases
- Lead sponsor
- Medical University of Graz
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- June 30, 2015
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myeloproliferative disorders, pulmonary hypertension